CLINICAL TRIALS PROFILE FOR BROVANA
✉ Email this page to a colleague
All Clinical Trials for BROVANA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00064402 ↗ | Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD | Completed | Sunovion | Phase 3 | 2002-04-01 | The purpose of this study is to assess the bronchodilator effect and safety of multiple daily doses of arformoterol administered for 12 weeks as maintenance treatment in patients with COPD |
| NCT00250679 ↗ | Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease | Completed | Sunovion | Phase 3 | 2005-10-01 | To evaluate the long-term safety and monitor the long-term efficacy of arformoterol over a period of 6 months in subjects with chronic obstructive pulmonary disease (COPD). |
| NCT00424528 ↗ | Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) | Completed | Sunovion | Phase 4 | 2006-12-01 | The purpose of this study is to evaluate and compare the efficacy of arformoterol twice a day and tiotropium once a day (dosed sequentially) versus tiotropium once a day alone in subjects with Chronic Obstructive Pulmonary Disease (COPD). |
| NCT00571428 ↗ | Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD | Completed | Sunovion | Phase 4 | 2007-11-01 | To evaluate the efficacy and safety of arformoterol tartrate inhalation solution 30μg/4mL QD (two 15μg/2mL dosed in combination) over a 24-hour period compared to arformoterol tartrate inhalation solution 15μg/2 mL BID in subjects with COPD. |
| NCT00583947 ↗ | A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects | Completed | Sunovion | Phase 2 | 2008-01-01 | To determine the safety and tolerability of Arformoterol Tartrate in children with asthma |
| NCT00685841 ↗ | A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | Completed | Sunovion | Phase 3 | 2002-02-01 | A 12 week study to investigate the safety and effectiveness of arformoterol given twice daily compared to placebo in subjects with COPD. |
| NCT00691405 ↗ | A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | Completed | Sunovion | Phase 2 | 2003-10-01 | A dose ranging study to evaluate the safety, tolerability and efficacy of arformoterol (given once or twice a day) in subjects with COPD. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BROVANA
Condition Name
Clinical Trial Locations for BROVANA
Trials by Country
Clinical Trial Progress for BROVANA
Clinical Trial Phase
Clinical Trial Sponsors for BROVANA
Sponsor Name
